BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bansal A, Lee IH, Hong X, Anand V, Mathur SC, Gaddam S, Rastogi A, Wani SB, Gupta N, Visvanathan M, Sharma P, Christenson LK. Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am J Gastroenterol 2011;106:1055-63. [PMID: 21407181 DOI: 10.1038/ajg.2011.37] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Kong X, Gong S, Su L, Li C, Kong Y. Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas. J Cell Mol Med. 2018;22:123-130. [PMID: 28799211 DOI: 10.1111/jcmm.13300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Guo J, Sun M, Teng X, Xu L. MicroRNA‑7‑5p regulates the expression of TFF3 in inflammatory bowel disease. Mol Med Rep 2017;16:1200-6. [PMID: 28627600 DOI: 10.3892/mmr.2017.6730] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yi Y, Lu X, Chen J, Jiao C, Zhong J, Song Z, Yu X, Lin B. Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma. Exp Ther Med. 2016;12:3411-3416. [PMID: 27882172 DOI: 10.3892/etm.2016.3783] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
4 Bansal A, Fitzgerald RC. Biomarkers in Barrett's Esophagus: Role in Diagnosis, Risk Stratification, and Prediction of Response to Therapy. Gastroenterol Clin North Am 2015;44:373-90. [PMID: 26021200 DOI: 10.1016/j.gtc.2015.02.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
5 Chen H, Fang Y, Tevebaugh W, Orlando RC, Shaheen NJ, Chen X. Molecular mechanisms of Barrett's esophagus. Dig Dis Sci 2011;56:3405-20. [PMID: 21984436 DOI: 10.1007/s10620-011-1885-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
6 Zhang G, Liu Z, Cui G, Wang X, Yang Z. MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells. Tumour Biol. 2014;35:11137-11145. [PMID: 25104088 DOI: 10.1007/s13277-014-2412-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 7.1] [Reference Citation Analysis]
7 Anaparthy R, Sharma P. Progression of Barrett oesophagus: role of endoscopic and histological predictors. Nat Rev Gastroenterol Hepatol 2014;11:525-34. [DOI: 10.1038/nrgastro.2014.69] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
8 Hemmatzadeh M, Mohammadi H, Karimi M, Musavishenas MH, Baradaran B. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer. Biomed Pharmacother. 2016;82:509-519. [PMID: 27470391 DOI: 10.1016/j.biopha.2016.05.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
9 Lee IH, Hong X, Mathur SC, Sharma M, Rastogi A, Sharma P, Christenson LK, Bansal A. A detailed analysis of next generation sequencing reads of microRNA expression in Barrett's esophagus: absolute versus relative quantification. BMC Res Notes 2014;7:212. [PMID: 24708854 DOI: 10.1186/1756-0500-7-212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Hou Y, Hu Q, Huang J, Xiong H. Omeprazole Inhibits Cell Proliferation and Induces G0/G1 Cell Cycle Arrest through Up-regulating miR-203a-3p Expression in Barrett's Esophagus Cells. Front Pharmacol 2017;8:968. [PMID: 29375376 DOI: 10.3389/fphar.2017.00968] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Amin M, Lam AK. Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management. Exp Mol Pathol 2015;98:411-8. [PMID: 25746664 DOI: 10.1016/j.yexmp.2015.03.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
12 Wallmark B. Omeprazole: mode of action and effect on acid secretion in animals. Methods Find Exp Clin Pharmacol. 1989;11 Suppl 1:101-106. [PMID: 2657278 DOI: 10.1007/s10620-015-3959-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
13 David S, Meltzer SJ. MicroRNA involvement in esophageal carcinogenesis. Curr Opin Pharmacol. 2011;11:612-616. [PMID: 21992930 DOI: 10.1016/j.coph.2011.09.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
14 Huang J, Zhang SY, Gao YM, Liu YF, Liu YB, Zhao ZG, Yang K. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Prolif. 2014;47:277-286. [PMID: 24909356 DOI: 10.1111/cpr.12109] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
15 Nwachokor J, Tawfik O, Danley M, Mathur S, House J, Sharma P, Christenson LK, Bansal A. Quantitation of spatial and temporal variability of biomarkers for Barrett's Esophagus. Dis Esophagus 2017;30:1-8. [PMID: 28859356 DOI: 10.1093/dote/dox023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Wang J, Tian X, Han R, Zhang X, Wang X, Shen H, Xue L, Liu Y, Yan X, Shen J. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene. 2014;33:1181-1189. [PMID: 23474761 DOI: 10.1038/onc.2013.42] [Cited by in Crossref: 141] [Cited by in F6Publishing: 154] [Article Influence: 15.7] [Reference Citation Analysis]
17 Fang Y, Chen X, Bajpai M, Verma A, Das KM, Souza RF, Garman KS, Donohoe CL, O’Farrell NJ, Reynolds JV. Cellular origins and molecular mechanisms of Barrett’s esophagus and esophageal adenocarcinoma. Ann N Y Acad Sci. 2013;1300:187-199. [PMID: 24117642 DOI: 10.1111/nyas.12249] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
18 Grady WM, Yu M, Markowitz SD, Chak A. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers. Cancer Epidemiol Biomarkers Prev 2020;29:2486-94. [PMID: 33093162 DOI: 10.1158/1055-9965.EPI-20-0223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chen H, Ren C, Han C, Wang D, Chen Y, Fu D. Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma. PLoS One. 2015;10:e0119384. [PMID: 25793394 DOI: 10.1371/journal.pone.0119384] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
20 Ding P, Luo J, Liang C, Xiao Q, Cao B. Human disease MiRNA inference by combining target information based on heterogeneous manifolds. J Biomed Inform 2018;80:26-36. [PMID: 29481877 DOI: 10.1016/j.jbi.2018.02.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
21 Billeter AT, Barnett RE, Druen D, Polk HC, van Berkel VH. MicroRNA as a New Factor in Lung and Esophageal Cancer. Semin Thorac Cardiovasc Surg. 2012;24:155-165. [PMID: 23200070 DOI: 10.1053/j.semtcvs.2012.06.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
22 Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI, Wang JS, Montgomery EA, Maitra A. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clin Cancer Res. 2013;19:4067-4078. [PMID: 23757351 DOI: 10.1158/1078-0432.ccr-13-0601] [Cited by in Crossref: 59] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
23 De A, Zhou J, Liu P, Huang M, Gunewardena S, Mathur SC, Christenson LK, Sharma M, Zhang Q, Bansal A. Forkhead box F1 induces columnar phenotype and epithelial-to-mesenchymal transition in esophageal squamous cells to initiate Barrett's like metaplasia. Lab Invest 2021;101:745-59. [PMID: 33495575 DOI: 10.1038/s41374-021-00534-4] [Reference Citation Analysis]
24 Morshedi K, Borran S, Ebrahimi MS, Masoud Khooy MJ, Seyedi ZS, Amiri A, Abbasi-Kolli M, Fallah M, Khan H, Sahebkar A, Mirzaei H. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review. Phytother Res 2021. [PMID: 34173992 DOI: 10.1002/ptr.7119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Fassan M, Croce CM, Rugge M. miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol 2011; 17(48): 5231-5239 [PMID: 22219591 DOI: 10.3748/wjg.v17.i48.5231] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
26 Revilla-Nuin B, Parrilla P, Lozano JJ, de Haro LF, Ortiz A, Martínez C, Munitiz V, de Angulo DR, Bermejo J, Molina J, Cayuela ML, Yélamos J. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study. Ann Surg 2013;257:886-93. [PMID: 23059500 DOI: 10.1097/SLA.0b013e31826ddba6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 4.9] [Reference Citation Analysis]
27 Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B, Streppel M, Canto M, Wang JS, Maitra A, Willis J, Markowitz SD, Barnholtz-Sloan J, Adams MD, Chak A, Guda K. The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Genes Chromosomes Cancer. 2012;51:473-479. [PMID: 22302717 DOI: 10.1002/gcc.21934] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
28 Clark RJ, Craig MP, Agrawal S, Kadakia M. microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review. Oncotarget 2018;9:8179-96. [PMID: 29487725 DOI: 10.18632/oncotarget.24145] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
29 Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, Guarnera MA, Li R, Cai L, Zhan M. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer. 2011;11:374. [PMID: 21864403 DOI: 10.1186/1471-2407-11-374] [Cited by in Crossref: 180] [Cited by in F6Publishing: 163] [Article Influence: 16.4] [Reference Citation Analysis]
30 Subramaniam D, Ponnurangam S, Ramamoorthy P, Standing D, Battafarano RJ, Anant S, Sharma P. Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One. 2012;7:e30590. [PMID: 22363450 DOI: 10.1371/journal.pone.0030590] [Cited by in Crossref: 152] [Cited by in F6Publishing: 134] [Article Influence: 15.2] [Reference Citation Analysis]
31 Sharma P, Sharma R. miRNA-mRNA crosstalk in esophageal cancer: From diagnosis to therapy. Crit Rev Oncol Hematol. 2015;96:449-462. [PMID: 26257289 DOI: 10.1016/j.critrevonc.2015.07.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
32 Fassan M, Volinia S, Palatini J, Pizzi M, Fernandez-Cymering C, Balistreri M, Realdon S, Battaglia G, Souza R, Odze RD. MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. Clin Transl Gastroenterol. 2013;4:e34. [PMID: 23677165 DOI: 10.1038/ctg.2013.5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
33 Garman KS, Owzar K, Hauser ER, Westfall K, Anderson BR, Souza RF, Diehl AM, Provenzale D, Shaheen NJ. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer. Dig Dis Sci. 2013;58:3178-3188. [PMID: 23925817 DOI: 10.1007/s10620-013-2806-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
34 Soares do Amaral N, Cruz E Melo N, de Melo Maia B, Malagoli Rocha R. Noncoding RNA Profiles in Tobacco- and Alcohol-Associated Diseases. Genes (Basel) 2016;8:E6. [PMID: 28025544 DOI: 10.3390/genes8010006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
35 Li SQ, Chen FJ, Cao XF. Distinctive microRNAs in esophageal tumor: early diagnosis, prognosis judgment, and tumor treatment. Dis Esophagus 2013;26:288-98. [PMID: 22458808 DOI: 10.1111/j.1442-2050.2012.01346.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
36 Link A, Goel A. MicroRNA in gastrointestinal cancer: a step closer to reality. Adv Clin Chem. 2013;62:221-268. [PMID: 24772669 DOI: 10.1016/b978-0-12-800096-0.00006-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
37 Zhang Q, Bansal A. Role of Extracellular Vesicles in the Diagnosis and Pathogenesis of Barrett's Esophagus: A Mini-Review. Dig Dis Sci 2021;66:705-13. [PMID: 32277372 DOI: 10.1007/s10620-020-06250-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Weaver JM, Ross-Innes CS, Fitzgerald RC. The '-omics' revolution and oesophageal adenocarcinoma. Nat Rev Gastroenterol Hepatol 2014;11:19-27. [PMID: 23982683 DOI: 10.1038/nrgastro.2013.150] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
39 Bansal A, Lee IH, Hong X, Mathur SC, Tawfik O, Rastogi A, Buttar N, Visvanathan M, Sharma P, Christenson LK. Discovery and validation of Barrett's esophagus microRNA transcriptome by next generation sequencing. PLoS One 2013;8:e54240. [PMID: 23372692 DOI: 10.1371/journal.pone.0054240] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
40 Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, Huang M, Wang KK, Hawk E. MicroRNA expression signatures during malignant progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila). 2013;6:196-205. [PMID: 23466817 DOI: 10.1158/1940-6207.capr-12-0276] [Cited by in Crossref: 72] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
41 Chiam K, Wang T, Watson DI, Mayne GC, Irvine TS, Bright T, Smith L, White IA, Bowen JM, Keefe D, Thompson SK, Jones ME, Hussey DJ. Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma. J Gastrointest Surg. 2015;19:1208-1215. [PMID: 25943911 DOI: 10.1007/s11605-015-2829-9] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 12.9] [Reference Citation Analysis]
42 Fels Elliott DR, Fitzgerald RC. Molecular markers for Barrett's esophagus and its progression to cancer. Curr Opin Gastroenterol. 2013;29:437-445. [PMID: 23689523 DOI: 10.1097/mog.0b013e328362282f] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
43 Liu AM, Yao TJ, Wang W, Wong KF, Lee NP, Fan ST, Poon RT, Gao C, Luk JM. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open 2012;2:e000825. [PMID: 22403344 DOI: 10.1136/bmjopen-2012-000825] [Cited by in Crossref: 158] [Cited by in F6Publishing: 157] [Article Influence: 15.8] [Reference Citation Analysis]
44 Kresty LA, Clarke J, Ezell K, Exum A, Howell AB, Guettouche T. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention. J Carcinog 2011;10:34. [PMID: 22279419 DOI: 10.4103/1477-3163.91110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
45 Gaur P, Hunt CR, Pandita TK. Emerging therapeutic targets in esophageal adenocarcinoma. Oncotarget 2016;7:48644-55. [PMID: 27102294 DOI: 10.18632/oncotarget.8777] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
46 Li X, Wainscott C, Xi Y. MicroRNA provides insight into understanding esophageal cancer: MicroRNA and esophageal cancer. Thoracic Cancer 2011;2:134-42. [DOI: 10.1111/j.1759-7714.2011.00059.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
47 Song C, Chen H, Wang T, Zhang W, Ru G, Lang J. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing. Prostate 2015;75:500-16. [PMID: 25597612 DOI: 10.1002/pros.22936] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
48 Ren C, Chen H, Han C, Fu D, Zhou L, Jin G, Wang F, Wang D, Chen Y, Ma L, Zheng X, Han D. miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value. Oncotarget 2016;7:15840-53. [PMID: 26895105 DOI: 10.18632/oncotarget.7417] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
49 Ding J, Li X, Hu H. CCmiR: a computational approach for competitive and cooperative microRNA binding prediction. Bioinformatics 2018;34:198-206. [PMID: 29028895 DOI: 10.1093/bioinformatics/btx606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Eluri S, Brugge WR, Daglilar ES, Jackson SA, Styn MA, Callenberg KM, Welch DC, Barr TM, Duits LC, Bergman JJ. The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus. Am J Gastroenterol. 2015;110:828-834. [PMID: 26010308 DOI: 10.1038/ajg.2015.152] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
51 Gaddam S, Singh M, Balasubramanian G, Thota P, Gupta N, Wani S, Higbee AD, Mathur SC, Horwhat JD, Rastogi A. Persistence of nondysplastic Barrett’s esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. Gastroenterology. 2013;145:548-553.e1. [PMID: 23714382 DOI: 10.1053/j.gastro.2013.05.040] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
52 Luo Y, Guda K, Markowitz SD, Chak A, Kaz AM, Grady WM. Esophageal Cancer Biomarkers. In: Srivastava S, editor. Biomarkers in Cancer Screening and Early Detection. Chichester: John Wiley & Sons, Ltd; 2017. pp. 104-17. [DOI: 10.1002/9781118468869.ch9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Gil-Gómez G, Fassan M, Nonell L, Garrido M, Climent M, Anglada R, Iglesias M, Guzzardo V, Borga C, Grande L, de Bolós C, Pera M. miR-24-3p regulates CDX2 during intestinalization of cardiac-type epithelium in a human model of Barrett's esophagus. Dis Esophagus 2021;34:doab005. [PMID: 33558874 DOI: 10.1093/dote/doab005] [Reference Citation Analysis]
54 Bansal A, Gupta V, Wang K. MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus. J Cell Biochem. 2016;117:1288-1295. [PMID: 26808728 DOI: 10.1002/jcb.25497] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
55 Akbari A, Sedaghat M, Heshmati J, Tabaeian SP, Dehghani S, Pizarro AB, Rostami Z, Agah S. Molecular mechanisms underlying curcumin-mediated microRNA regulation in carcinogenesis; Focused on gastrointestinal cancers. Biomed Pharmacother 2021;141:111849. [PMID: 34214729 DOI: 10.1016/j.biopha.2021.111849] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
56 Li T, Guo H, Li H, Jiang Y, Zhuang K, Lei C, Wu J, Zhou H, Zhu R, Zhao X, Lu Y, Shi C, Nie Y, Wu K, Yuan Z, Fan DM, Shi Y. MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia. Gut 2019;68:1751-63. [PMID: 30635407 DOI: 10.1136/gutjnl-2017-315318] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
57 Eluri S, Shaheen NJ. Barrett's esophagus: diagnosis and management. Gastrointest Endosc. 2017;85:889-903. [PMID: 28109913 DOI: 10.1016/j.gie.2017.01.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]